During the past decade, Hamad medical corporation conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 1 clinical trials were completed, i.e. on average, 1.7% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hamad medical corporation" #1 sponsor was "Hamad Medical Corporation" with 47 trials, followed by "Weill Medical College of Cornell University" with 12 trials sponsored, "Weill Cornell Medical College in Qatar" with 4 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 3 trials sponsored and "Pfizer" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hamad medical corporation" #1 collaborator was "Hamad Medical Corporation" with 16 trials as a collaborator, "Weill Cornell Medical College in Qatar" with 12 trials as a collaborator, "Qatar University" with 3 trials as a collaborator, "AOCMF" with 2 trials as a collaborator and "Sidra Medical and Research Center" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Hamad medical corporation" are "Diabetes Mellitus" (5 trials), "Type 2 Diabetes" (5 trials), "COVID-19" (4 trials), "Covid19" (4 trials) and "Asthma" (3 trials). Many other conditions were trialed in "Hamad medical corporation" in a lesser frequency.

Most popular intervention types in "Hamad medical corporation" are "Drug" (26 trials), "Other" (16 trials), "Device" (8 trials), "Diagnostic Test" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Calcitriol" (2 trials), "Dexamethasone Oral" (2 trials), "Placebo" (2 trials), "10-week exercise programme based on aerobic interval and resistance training" (1 trials) and "Adjuvant non-surgical treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hamad medical corporation" are 72 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 22 active trials in "Hamad medical corporation". 1 are not yet recruiting, 19 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Hamad medical corporation, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hamad medical corporation, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 21 trials that are defined as “Not Applicable".

Hamad medical corporation has several departments that took part in Clinical trials: "National Center for Cancer Care & Research (NCCCR)" - 4 trials, "Pediatric Emergency Center, Al Saad" - 4 trials, "Heart Hospital, Hamad Medical Coorporation" - 3 trials, "Fahd Bin Jassem Dialysis Centre" - 2 trials, "Hamad Medical Corporation, Pediatric Emergency Center,Alsaad." - 2 trials